Cyclic cell adhesion modulation compounds

Details Cyclic cell adhesion modulation compounds Cyclic cell adhesion modulation compounds

1995-06-07

1998-02-24

Tsang, Cecilia J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 16, 514 17, 514 18, 530317, 530328, 530329, 530330, A61K 3800, C07K 3702, C07K 512, C07K 706

Patent

active

057212104

ABSTRACT:
Cyclized integrin receptor antagonist compounds useful in modulating cell adhesion, including adhesion related to fibronectin, as well as leukocyte adhesion to endothelial cells, are disclosed. Methods for synthesizing, testing, formulating, and using the compounds as therapeutic agents are also disclosed.

REFERENCES:
patent: 4988621 (1991-01-01), Ruoslahti et al.
patent: 5192746 (1993-03-01), Lobl et al.
Pierschbacher et al, vol. 202, No. 26, pp. 17294-17298.
ASM News, vol. 56, p. 368 (Jul. 1990).
Sandstrom, et al., Drugs, vol. 34, pp. 372-390 (1987).
Tavoff, Time , pp. 56-64, May 13, 1988.
Blumenstein, et al., Biochem T. Bio. Res. Comm. , vol. 163, p. 980 (1989).
Johnson, et al., Cancer Treatment Reviews, vol. 2, pp. 1-31 (1975).

Affiliated with

Also associated with

Rating

Cyclic cell adhesion modulation compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic cell adhesion modulation compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic cell adhesion modulation compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1875222